Pages that link to "Q44285793"

The following pages link to Increased expression of bone morphogenetic protein-7 in bone metastatic prostate cancer (Q44285793):

Displaying 48 items.

• Tumor metastasis to bone (Q21195416) (← links)
• Discovery of novel hypermethylated genes in prostate cancer using genomic CpG island microarrays (Q21562455) (← links)
• DNA methylation-associated inactivation of TGFbeta-related genes DRM/Gremlin, RUNX3, and HPP1 in human cancers (Q24650975) (← links)
• BMP-7 enhances cell migration and αvβ3 integrin expression via a c-Src-dependent pathway in human chondrosarcoma cells (Q28544902) (← links)
• BMP7: a new bone metastases prevention? (Q30443506) (← links)
• Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms (Q30482634) (← links)
• Aggressive melanoma cells escape from BMP7-mediated autocrine growth inhibition through coordinated Noggin upregulation. (Q30487367) (← links)
• Bone morphogenetic protein 7 is expressed in prostate cancer metastases and its effects on prostate tumor cells depend on cell phenotype and the tumor microenvironment (Q33622608) (← links)
• BMP2 promotes proliferation and invasion of nasopharyngeal carcinoma cells via mTORC1 pathway (Q33657520) (← links)
• Src family kinase/abl inhibitor dasatinib suppresses proliferation and enhances differentiation of osteoblasts. (Q34067118) (← links)
• The Yin and Yang of bone morphogenetic proteins in cancer (Q34127207) (← links)
• Combined inhibition of the BMP pathway and the RANK-RANKL axis in a mixed lytic/blastic prostate cancer lesion (Q34574593) (← links)
• Effect of Bone Morphogenetic Protein-2 on Proliferation and Apoptosis of Gastric Cancer Cells (Q35770191) (← links)
• Suppression of Hepatocyte Proliferation by Hepatocyte Nuclear Factor 4α in Adult Mice (Q35801944) (← links)
• Hic-5 controls BMP4 responses in prostate cancer cells through interacting with Smads 1, 5 and 8 (Q35923246) (← links)
• Gene expression analysis of bone metastasis and circulating tumor cells from metastatic castrate-resistant prostate cancer patients (Q35956586) (← links)
• Genetic variants in CASP3, BMP5, and IRS2 genes may influence survival in prostate cancer patients receiving androgen-deprivation therapy (Q36109818) (← links)
• Safety and efficacy of use of demineralised bone matrix in orthopaedic and trauma surgery (Q36624999) (← links)
• Prostate cancer bone metastases acquire resistance to androgen deprivation via WNT5A-mediated BMP-6 induction (Q37650625) (← links)
• Steps in prostate cancer progression that lead to bone metastasis (Q37848782) (← links)
• Neoplasia following use of BMPs: is there an increased risk? (Q38256860) (← links)
• Putative prognostic epithelial-to-mesenchymal transition biomarkers for aggressive prostate cancer (Q38395325) (← links)
• Bone morphogenetic protein signaling in musculoskeletal cancer (Q38797636) (← links)
• Hepcidin regulation in prostate and its disruption in prostate cancer. (Q38889135) (← links)
• Prostate cancer cells and bone stromal cells mutually interact with each other through bone morphogenetic protein-mediated signals. (Q39359077) (← links)
• Effects of the bone morphogenetic protein binding protein spp24 (secreted phosphoprotein 24 kD) on the growth of human lung cancer cells (Q39555278) (← links)
• Prostate cancer cells modulate osteoblast mineralisation and osteoclast differentiation through Id-1. (Q39763199) (← links)
• Runx2 regulates survivin expression in prostate cancer cells (Q39769098) (← links)
• The Bone Morphogenesis Protein-2 (BMP-2) is associated with progression to metastatic disease in gastric cancer (Q39811419) (← links)
• Bone morphogenetic protein 7 is widely overexpressed in primary breast cancer (Q40328309) (← links)
• BMP signals inhibit proliferation and in vivo tumor growth of androgen-insensitive prostate carcinoma cells (Q40494529) (← links)
• Loss of expression of bone morphogenetic protein receptor type II in human prostate cancer cells (Q40518052) (← links)
• Differential expression of bone morphogenetic protein 5 in human lung squamous cell carcinoma and adenocarcinoma. (Q41213157) (← links)
• Bone Morphogenetic Protein Signaling: Implications in Urology (Q41783158) (← links)
• Exploration of Shh and BMP paracrine signaling in a prostate cancer xenograft (Q42695596) (← links)
• Serum follistatin in patients with prostate cancer metastatic to the bone. (Q42972965) (← links)
• BMP-2 expression correlates with local failure in head and neck squamous cell carcinoma. (Q46063070) (← links)
• The BMP antagonist Noggin is produced by osteoblasts in response to the presence of prostate cancer cells (Q47691810) (← links)
• Differential regulation of hepcidin in cancer and non-cancer tissues and its clinical implications. (Q49389245) (← links)
• Bone morphogenetic protein-2 levels are elevated in the patients with gastric cancer and correlate with disease progression. (Q53359173) (← links)
• HGF/SF up-regulates the expression of bone morphogenetic protein 7 in prostate cancer cells. (Q53547774) (← links)
• Decreased expression of bone morphogenetic protein-2 is correlated with biochemical recurrence in prostate cancer: Immunohistochemical analysis. (Q55714340) (← links)
• Prostate Cancer and Bone Metastases: The Underlying Mechanisms. (Q64888853) (← links)
• Augmented autocrine bone morphogenic protein (BMP) 7 signaling increases the metastatic potential of mouse breast cancer cells (Q83318737) (← links)
• Two new, near-infrared, fluorescent probes as potential tools for imaging bone repair (Q89701815) (← links)
• Expression Of BMP7 In Ovarian Cancer And Biological Effect Of BMP7 Knockdown On Ovarian Cancer Cells (Q90427409) (← links)
• Hedgehog Signaling for Urogenital Organogenesis and Prostate Cancer: An Implication for the Epithelial-Mesenchyme Interaction (EMI) (Q92156012) (← links)
• Bone morphogenic proteins-2, -4, -6 and 7 in non-muscle invasive bladder cancer (Q92835270) (← links)